Observational study on outcomes of primary intracerebral hemorrhage in hospitalized adults
Clinical Outcomes Following Primary Intracerebral Hemorrhage：A Multicenter Cohort Study
This study looks at hospitalized adults with bleeding in the brain to see how common it is, what treatments they get, and how well they do after being treated.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 25000 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Trial ID | NCT06548737 on ClinicalTrials.gov |
What this trial studies
This observational cohort study analyzes data from six stroke centers in Zhejiang Province, China, focusing on hospitalized adult patients with primary intracerebral hemorrhage (ICH). The study aims to gather contemporary information regarding the prevalence, characteristics, risk stratification, cost-effectiveness, treatments, and prognosis of these patients. Data is collected by trained registrars using standardized protocols, with oversight from a steering committee to ensure quality and accuracy. Patients included in the study must have undergone specific diagnostic tests upon admission and not received neurosurgical interventions.
Who should consider this trial
Good fit: Ideal candidates for this study are hospitalized adult patients diagnosed with primary intracerebral hemorrhage who meet specific inclusion criteria.
Not a fit: Patients with intracerebral hemorrhage secondary to known causes or those who had significant disability prior to the current episode may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the management and outcomes of primary intracerebral hemorrhage, potentially improving patient care and treatment strategies.
How similar studies have performed: Other studies focusing on outcomes of stroke and intracerebral hemorrhage have shown success, indicating that this approach is supported by previous research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: \- We included adult patients who (1) admitted for primary ICH ; (2) underwent blood routine test (hemoglobin included) and CT scan as soon as they arrived at hospital; (3) were not treated with neurosurgical procedures. Exclusion Criteria: * We excluded patients who (1) had ICH secondary to known causes, including trauma, intracranial neoplasm and systemic diseases12, as well as anticoagulative agents; or had isolated intraventricular hemorrhage (IVH); (2) mRS \>2 before the current ICH episode (according to past medical records or description from guardians.
Where this trial is running
Hangzhou, Zhejiang
- The Second Affiliated Hospital of Zhejiang University — Hangzhou, Zhejiang, China (Recruiting)
Study contacts
- Study coordinator: Feng Gao, Dr
- Email: 2202012@zju.edu.cn
- Phone: +86-13588451471
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.